Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"
DOI: 10.1016/j.jctube.2020.100201
Abstract: Background In 2019, the World Health Organization released guidelines reflecting major changes in multidrug-resistant tuberculosis (MDR-TB) management—prioritizing fluoroquinolones, bedaquiline, and linezolid (LZD) while de-emphasizing previously favored injectable agents. In some cases, linezolid use is associated… read more here.
Keywords: use; mdr; linezolid use; tuberculosis ... See more keywords
Linezolid use and drug-induced liver injury
Sign Up to like & getrecommendations! Published in 2020 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2020.1855922
Abstract: Abstract Linezolid is a frequently prescribed antibiotic for chronic infection suppression, such as in prosthetic joint infections. While well tolerated, its prolonged use can increase the risk of rare and serious side effects. We present… read more here.
Keywords: induced liver; linezolid use; liver injury; drug induced ... See more keywords
Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys
Sign Up to like & getrecommendations! Published in 2019 at "Antimicrobial Resistance and Infection Control"
DOI: 10.1186/s13756-019-0617-0
Abstract: BackgroundLinezolid belongs to a reserve group of antibiotics. In recent years, reports on linezolid resistance in gram-positive cocci have become more frequent. Overuse of linezolid is a relevant factor for resistance development. The objective of… read more here.
Keywords: national point; prevalence surveys; linezolid use; consecutive national ... See more keywords